CONSTELLATION BRANDS, INC. Stock Compensation Disclosure
| For the Years Ended | |||||||||||||||||
| February 28, 2026 | February 28, 2025 | February 29, 2024 | |||||||||||||||
| (in millions) | |||||||||||||||||
Total compensation cost recognized in our results of operations (1) | $ | 69.2 | $ | 72.2 | $ | 63.6 | |||||||||||
| Income tax benefit related thereto recognized in our results of operations | $ | 10.2 | $ | 10.6 | $ | 9.5 | |||||||||||
| For the Years Ended | |||||||||||||||||||||||||||||||||||
| February 28, 2026 | February 28, 2025 | February 29, 2024 | |||||||||||||||||||||||||||||||||
| Number of Options | Weighted Average Exercise Price | Number of Options | Weighted Average Exercise Price | Number of Options | Weighted Average Exercise Price | ||||||||||||||||||||||||||||||
| Outstanding as of March 1 | 2,258,033 | $ | 212.95 | 2,564,288 | $ | 203.47 | 3,067,962 | $ | 194.47 | ||||||||||||||||||||||||||
| Granted | — | $ | — | 124,418 | $ | 260.11 | 151,848 | $ | 226.76 | ||||||||||||||||||||||||||
| Exercised | (59,844) | $ | 141.77 | (393,016) | $ | 162.80 | (584,302) | $ | 160.41 | ||||||||||||||||||||||||||
| Forfeited | (26,800) | $ | 248.81 | (29,237) | $ | 246.98 | (55,351) | $ | 225.04 | ||||||||||||||||||||||||||
| Expired | (168,175) | $ | 209.04 | (8,420) | $ | 245.19 | (15,869) | $ | 196.57 | ||||||||||||||||||||||||||
| Outstanding as of last day of February | 2,003,214 | $ | 214.93 | 2,258,033 | $ | 212.95 | 2,564,288 | $ | 203.47 | ||||||||||||||||||||||||||
| Exercisable | 1,814,172 | $ | 211.19 | 1,761,492 | $ | 203.26 | 1,702,984 | $ | 193.68 | ||||||||||||||||||||||||||
| For the Years Ended | |||||||||||||||||
| February 28, 2026 | February 28, 2025 | February 29, 2024 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Fair value of stock options vested | $ | 19.0 | $ | 23.6 | $ | 27.3 | |||||||||||
| Intrinsic value of stock options exercised | $ | 2.4 | $ | 34.6 | $ | 54.6 | |||||||||||
| Tax benefit realized from stock options exercised | $ | 0.6 | $ | 5.4 | $ | 10.4 | |||||||||||
For the Years Ended (1) | |||||||||||
| February 28, 2025 | February 29, 2024 | ||||||||||
| Grant-date fair value | $ | 78.32 | $ | 64.75 | |||||||
Expected life (2) | 5.8 years | 5.8 years | |||||||||
Expected volatility (3) | 27.8% | 28.8% | |||||||||
Risk-free interest rate (4) | 4.7% | 3.6% | |||||||||
Expected dividend yield (5) | 1.6% | 1.6% | |||||||||
| For the Years Ended | |||||||||||||||||||||||||||||||||||
| February 28, 2026 | February 28, 2025 | February 29, 2024 | |||||||||||||||||||||||||||||||||
| Number | Weighted Average Grant-Date Fair Value | Number | Weighted Average Grant-Date Fair Value | Number | Weighted Average Grant-Date Fair Value | ||||||||||||||||||||||||||||||
| Restricted Stock Units | |||||||||||||||||||||||||||||||||||
| Outstanding balance as of March 1, Nonvested | 333,985 | $ | 246.73 | 335,614 | $ | 228.75 | 291,859 | $ | 223.75 | ||||||||||||||||||||||||||
| Granted | 327,972 | $ | 183.23 | 171,601 | $ | 260.44 | 192,300 | $ | 227.30 | ||||||||||||||||||||||||||
| Vested | (155,194) | $ | 243.70 | (139,589) | $ | 220.63 | (116,937) | $ | 213.83 | ||||||||||||||||||||||||||
| Forfeited | (94,902) | $ | 211.26 | (33,641) | $ | 245.56 | (31,608) | $ | 228.90 | ||||||||||||||||||||||||||
| Outstanding balance as of last day of February, Nonvested | 411,861 | $ | 205.48 | 333,985 | $ | 246.73 | 335,614 | $ | 228.75 | ||||||||||||||||||||||||||
| For the Years Ended | |||||||||||||||||||||||||||||||||||
| February 28, 2026 | February 28, 2025 | February 29, 2024 | |||||||||||||||||||||||||||||||||
| Number | Weighted Average Grant-Date Fair Value | Number | Weighted Average Grant-Date Fair Value | Number | Weighted Average Grant-Date Fair Value | ||||||||||||||||||||||||||||||
| Performance Share Units | |||||||||||||||||||||||||||||||||||
| Outstanding balance as of March 1, Nonvested | 140,072 | $ | 289.31 | 110,061 | $ | 292.78 | 85,649 | $ | 302.06 | ||||||||||||||||||||||||||
| Granted | 83,741 | $ | 192.64 | 57,804 | $ | 290.73 | 67,734 | $ | 238.01 | ||||||||||||||||||||||||||
Performance achievement (1) | (26,457) | $ | 395.57 | (6,366) | $ | 318.71 | (10,725) | $ | 202.53 | ||||||||||||||||||||||||||
| Vested | — | $ | — | (14,485) | $ | 318.71 | (21,848) | $ | 202.53 | ||||||||||||||||||||||||||
| Forfeited | (17,717) | $ | 247.48 | (6,942) | $ | 267.90 | (10,749) | $ | 295.07 | ||||||||||||||||||||||||||
| Outstanding balance as of last day of February, Nonvested | 179,639 | $ | 232.72 | 140,072 | $ | 289.31 | 110,061 | $ | 292.78 | ||||||||||||||||||||||||||
| For the Years Ended | |||||||||||||||||
| February 28, 2026 | February 28, 2025 | February 29, 2024 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Restricted stock units | $ | 28.7 | $ | 35.4 | $ | 27.0 | |||||||||||
| Performance share units | $ | — | $ | 3.7 | $ | 5.0 | |||||||||||
| For the Years Ended | |||||||||||||||||
| February 28, 2026 | February 28, 2025 | February 29, 2024 | |||||||||||||||
| Grant-date fair value | $ | 192.64 | $ | 324.98 | $ | 251.63 | |||||||||||
| Grant-date price | $ | 183.61 | $ | 261.71 | $ | 224.38 | |||||||||||
| Performance period | 2.8 years | 2.9 years | 2.9 years | ||||||||||||||
Expected volatility (1) | 24.5 | % | 20.4 | % | 23.8 | % | |||||||||||
Risk-free interest rate (2) | 3.7 | % | 4.7 | % | 3.8 | % | |||||||||||
Expected dividend yield (3) | 0.0 | % | 0.0 | % | 0.0 | % | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Apr 22, 2026 | Showing above |
| 2025 | Apr 23, 2025 | |
| 2024 | Apr 23, 2024 | |
| 2018 | Apr 23, 2018 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.